Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
SYLA Technologies Co., Ltd. - American Depositary Shares | SYT | Jan 17, 2025 | 1.64 | +5.22 |
Sylvamo | SLVM | Jan 17, 2025 | 78.15 | -1.40 |
Symbotic | SYM | Jan 17, 2025 | 29.76 | -6.47 |
Synaptics | SYNA | Jan 17, 2025 | 83.14 | +2.78 |
Synaptogenix | SNPX | Jan 17, 2025 | 3.30 | 0.00 |
Synchronoss Technologies | SNCR | Jan 17, 2025 | 10.17 | +10.91 |
Synchrony Financial | SYF | Jan 17, 2025 | 68.75 | +1.39 |
Synchrony Financial Pref A | SYF-B | Jan 17, 2025 | 26.19 | -0.27 |
Synchrony Financial Pref A | SYF-A | Jan 17, 2025 | 19.25 | -0.77 |
Syndax Pharmaceuticals | SNDX | Jan 17, 2025 | 13.08 | +0.62 |
Synergetics Inc | FTGC | Jan 17, 2025 | 25.02 | -0.24 |
Synergy CHC | SNYR | Jan 17, 2025 | 4.07 | 0.00 |
Synlogic | SYBX | Jan 17, 2025 | 1.46 | +0.69 |
Synopsys | SNPS | Jan 17, 2025 | 526.70 | +2.11 |
Synovus Financial | SNV | Jan 17, 2025 | 54.61 | +0.70 |
Synovus Financial D Pref | SNV-D | Jan 17, 2025 | 25.07 | +0.12 |
Synovus Financial E Pref | SNV-E | Jan 17, 2025 | 25.82 | -0.35 |
Syntec Optics | OPTX | Jan 17, 2025 | 1.92 | -5.88 |
Sypris Solutions | SYPR | Jan 17, 2025 | 1.94 | -8.92 |
Syra Health | SYRA | Jan 17, 2025 | 0.49 | -1.98 |
Syros Pharmaceuticals | SYRS | Jan 17, 2025 | 0.22 | +7.02 |
Sysco | SYY | Jan 17, 2025 | 73.07 | -0.20 |
System1 A | SST | Jan 17, 2025 | 0.61 | -1.60 |
T Stamp A | IDAI | Jan 17, 2025 | 4.58 | +3.85 |
T-Mobile US | TMUS | Jan 17, 2025 | 218.97 | +1.49 |
T. Rowe Price Blue Chip Growth ETF | TCHP | Jan 17, 2025 | 42.80 | +0.97 |
T. Rowe Price Dividend Growth ETF | TDVG | Jan 17, 2025 | 40.57 | +0.40 |
T. Rowe Price Equity Income ETF | TEQI | Jan 17, 2025 | 41.97 | +0.65 |
T. Rowe Price Group | TROW | Jan 17, 2025 | 113.21 | +0.96 |
T. Rowe Price Growth Stock ETF | TGRW | Jan 17, 2025 | 40.13 | +1.06 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.